Pelicon Pharmaceutical Pvt Ltd
About Pelicon Pharmaceutical Pvt Ltd
Data last updated:
Pelicon Pharmaceutical Pvt Ltd is a private limited company based in Nandabhanga, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1980PTC032999.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24 Lakh. It is led by directors Suman Sarawagi and Ratan Kumar Sarawagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vill – Nandabhanga P.O – Kanganberia P.S. Bishnupur, West Bengal, India – 743503.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.68 Cr. For the same year it recorded a net profit of ₹1.38 Cr (net margin 81.8%) and EBITDA of -₹14.08 Lakh (EBITDA margin -8.4%).
As per MCA filings, the company has satisfied charges of ₹4.64 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pelicon Pharmaceutical Pvt Ltd's registered office is in Nandabhanga, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVill – Nandabhanga P.O – Kanganberia P.S. Bishnupur, West Bengal, India – 743503
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pelicon Pharmaceutical Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Pelicon Pharmaceutical Pvt Ltd
FY 2025 filings availablePelicon Pharmaceutical Pvt Ltd reported revenue of ₹1.68 Cr for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.68 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹14.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.4% | ||||
| Net Profit Margin | 81.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pelicon Pharmaceutical Pvt Ltd, buy the company report.
Board of directors of Pelicon Pharmaceutical Pvt Ltd
Pelicon Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Sarawagi Also directs: Varun Polyplast India Private Limited | Director | 01 Dec 2018 | 7 Years 11 Months | Current |
| Ratan Kumar Sarawagi Also directs: Varun Polyplast India Private Limited | Director | 16 Nov 2017 | 8 Years 11 Months | Current |
Auditor
Pelicon Pharmaceutical Pvt Ltd is audited by S.D.JHA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.D.JHA & ASSOCIATES | FY 2022 | 317180E |
Shareholding
The shareholding of Pelicon Pharmaceutical Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pelicon Pharmaceutical Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2005 | 90249386 | State Bank of India | ₹2.88 Cr | Satisfied | |
| 10 Sep 2003 | 90249290 | Bank of Baroda | ₹1.76 Cr | Satisfied |
To see the full charge records of Pelicon Pharmaceutical Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Pelicon Pharmaceutical Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pelicon Pharmaceutical Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pelicon Pharmaceutical Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pelicon Pharmaceutical Pvt Ltd has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Ajay Kumar Tiwary ceased to be Director on 01 Dec 2018.
2 earlier events are in the company report.
Frequently asked questions
Pelicon Pharmaceutical is an active private limited company based in Nandabhanga, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 1980 (46+ years old) and is registered under CIN U24231WB1980PTC032999.
Pelicon Pharmaceutical has 2 current directors:
- Suman Sarawagi - Director
- Ratan Kumar Sarawagi - Director
The latest financial statements of Pelicon Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Pelicon Pharmaceutical is U24231WB1980PTC032999. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pelicon Pharmaceutical was incorporated on 18 September 1980, making it 46+ years old. It is registered with the Registrar of Companies, Kolkata.
Ajay Kumar Tiwary ceased to be Director on 01 Dec 2018. Suman Sarawagi was appointed as Director on 01 Dec 2018. Hiralal Patel ceased to be Director on 16 Nov 2017. Pelicon Pharmaceutical has 7 board changes on record in total.
The registered office of Pelicon Pharmaceutical is at Vill – Nandabhanga P.O – Kanganberia P.S. Bishnupur, West Bengal, India – 743503.
Pelicon Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Pelicon Pharmaceutical has no open charges and satisfied charges of ₹4.64 Cr as per latest MCA filings.
The compliance status of Pelicon Pharmaceutical is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
